Innovation Stock Price, News & Analysis
Company Description
Innovation (OTC Link: IPIX) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $1.0M.
IPIX stock has gained 100.0% over the past year. Shares last traded at $0.0007.
On a trailing twelve-month basis, Innovation reported revenue of $0 with net income of -$3.2M.
This page provides a comprehensive overview of IPIX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Innovation (IPIX) stock last traded at $0.0007, down 42.86% from the previous close. Over the past 12 months, the stock has gained 100.0%. At a market capitalization of $1.0M, IPIX is classified as a micro-cap stock with approximately 518.3M shares outstanding.
Latest News
Innovation has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, fda approval, clinical trial. View all IPIX news →
SEC Filings
Financial Highlights
Innovation generated $0 in revenue over the trailing twelve months, operating income reached -$3.1M, and net income was -$3.2M. The company generated -$2.1M in operating cash flow. With a current ratio of 0.33, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
IPIX Company Profile & Sector Positioning
Innovation (IPIX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing IPIX often look at related companies in the same sector, including Biocure Technolo (BICTF), Psybio Therapeau (PSYBF), Braxia Scientifi (BRAXF), BIORA THERAPEUTICS INC (BIOR), and Yulong Eco-Matls Ltd (YECO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IPIX's relative position within its industry.